Pages that link to "Q34682512"
The following pages link to Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity. (Q34682512):
Displaying 12 items.
- NMR mapping of RANTES surfaces interacting with CCR5 using linked extracellular domains (Q24324423) (← links)
- Elucidating a key anti-HIV-1 and cancer-associated axis: the structure of CCL5 (Rantes) in complex with CCR5. (Q27309182) (← links)
- Physical exercise reduces the expression of RANTES and its CCR5 receptor in the adipose tissue of obese humans (Q33594449) (← links)
- The CD8-derived chemokine XCL1/lymphotactin is a conformation-dependent, broad-spectrum inhibitor of HIV-1. (Q35079838) (← links)
- Dipeptidyl peptidase IV inhibition does not adversely affect immune or virological status in HIV infected men and women: a pilot safety study (Q36589398) (← links)
- Characterization of structure, dynamics, and detergent interactions of the anti-HIV chemokine variant 5P12-RANTES. (Q37368217) (← links)
- Using glycosaminoglycan/chemokine interactions for the long-term delivery of 5P12-RANTES in HIV prevention (Q37458024) (← links)
- Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5 (Q41897622) (← links)
- Biophysical and structural investigation of bacterially expressed and engineered CCR5, a G protein-coupled receptor (Q44679352) (← links)
- RANTES levels as a determinant of falciparum malaria severity or recovery. (Q44853870) (← links)
- Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers (Q47800411) (← links)
- Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions (Q89729129) (← links)